Table 4.
Disease-free interval (DFI), median survival time (MST), and percentage of local recurrence (LR) and lung metastasis (LM) for each group, calculated up to June 30st, 2013
| Group | DFI (days) | MST (days) | LR | LM |
|---|---|---|---|---|
| Overall population (n=33) | 290 (191−∞)a | 370 (320−∞)a | 27.3% | 56.7% (17/30)b |
| Group I (n=14) | 477 (207−∞) | 653 (458−∞) | 21.4% | 35.7% (5/14) |
| Group II (n=13) | 180 (131−∞) | 220 (174−∞) | 38.5% | 90.0% (9/10) |
| Group III (n=6) | 250 (178−∞) | 338 (223−∞) | 16.7% | 50.0% (3/6) |
| Group II+III (n=19) | 180 (165−∞) | 224 (185−∞) | 31.6% | 75.0% (12/16) |
a
(LCL95%-UCL95%) Lower-Upper Control Limits
b
number of affected patients over those for which the data were available